Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species

BACKGROUND: Cost-effectiveness studies of echinocandins for the treatment of invasive candidiasis, including candidemia, are rare in Asia. No study has determined whether echinocandins are cost-effective for both Candida albicans and non-albicans Candida species. There have been no economic evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Huang-Tz, Lee, Tsung-Ying, Chen, Yee-Chun, Charbonneau, Claudie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504557/
https://www.ncbi.nlm.nih.gov/pubmed/28693479
http://dx.doi.org/10.1186/s12879-017-2573-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504557/
https://www.ncbi.nlm.nih.gov/pubmed/28693479
http://dx.doi.org/10.1186/s12879-017-2573-8

Ejemplares similares